Evoke Pharma, Inc. (EVOK)
11.00
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Evoke Pharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.520 |
| June 30, 2025 | 1.172 |
| March 31, 2025 | 0.8808 |
| December 31, 2024 | 0.7332 |
| September 30, 2024 | 1.140 |
| June 30, 2024 | 1.876 |
| March 31, 2024 | 1.430 |
| December 31, 2023 | -1.938 |
| September 30, 2023 | -5.738 |
| June 30, 2023 | 9.385 |
| March 31, 2023 | 2.395 |
| December 31, 2022 | 1.256 |
| September 30, 2022 | 0.9315 |
| June 30, 2022 | 0.6953 |
| March 31, 2022 | 2.585 |
| December 31, 2021 | 1.410 |
| September 30, 2021 | 1.058 |
| June 30, 2021 | 0.8524 |
| March 31, 2021 | 0.6554 |
| December 31, 2020 | -1.632 |
| September 30, 2020 | -1.113 |
| June 30, 2020 | -5.821 |
| March 31, 2020 | 0.0361 |
| December 31, 2019 | 0.0316 |
| September 30, 2019 | 0.0068 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.011 |
| March 31, 2019 | 0.0336 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -2.882 |
| March 31, 2016 | 5.797 |
| December 31, 2015 | 1.264 |
| September 30, 2015 | 0.8231 |
| June 30, 2015 | 1.010 |
| March 31, 2015 | 0.6841 |
| December 31, 2014 | 0.478 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.1409 |
| December 31, 2013 | 0.1395 |
| September 30, 2013 | 0.1534 |
| June 30, 2013 | -1.52 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5477 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.65M |
| Total Liabilities (Quarterly) | 12.29M |
| Shareholders Equity (Quarterly) | 3.362M |